Details for 2016001284

Up to date per 02.04.2026

Actions

Title / Product Name

TARGETING VON LIPIDEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016001284

EP Publication Number

3156077

E-Number

1473567

Language

PCT Number

Publication Date

19.04.2017 A

09.03.2022 B1

Registration Date

09.03.2022

AT Publication Date

15.03.2022

Application Date

04.12.2008

Registration Number

Priorities

04.12.2007

992309 P

13.12.2007

13597 P

14.05.2008

127751 P

22.08.2008

91093 P

16.09.2008

97261 P

IPC

A61K 31/70 20060101AFI20210708BHEP

Maximum Duration of Protection

04.12.2028

Owner

Arbutus Biopharma Corporation100- 8900 Glenlyon Parkway Burnaby, BC V5J 5J8CA

Representative

No representatives present

Inventor

Manoharan, Muthiahc/o Alnylam Pharmaceuticals Inc., 300 Third Street Cambridge, MA 02142US

Rajeev, Kallanthottathil, G.c/o Alnylam Pharmaceuticals Inc., 300 Third Street Cambridge, MA 02142US

Narayanannair, Jayaprakash, K.c/o Alnylam Pharmaceuticals Inc., 300 Third Street Cambridge, MA 02142US

Jayaraman, Muthusamyc/o Alnylam Pharmaceuticals Inc., 300 Third Street Cambridge, MA 02142US